Sansure Biotech (688289.SS) Earnings Analysis
Sansure Biotech (688289.SS) next reports earnings on 2026-08-27. Trailing P/E 57.31.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688289.SS next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.44B |
688289.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.08 CNY | n/a | n/a | n/a |
| 2026-02-27 | 0.0115 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.04 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.1672 CNY | n/a | n/a | n/a |
| 2024-08-18 | 0.132 CNY | n/a | n/a | n/a |
688289.SS valuation and analyst view
| Trailing P/E | 57.31 |
|---|---|
| Trailing EPS | 0.25242 CNY |
| Price / book | 1.29 |
| Dividend yield | 3.51% |
| Market cap | 8.71B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sansure Biotech (688289.SS)'s next earnings date?
Sansure Biotech is next scheduled to report on 2026-08-27 and revenue estimate of 0.44B.
Did 688289.SS beat earnings last quarter?
Consensus estimate data was not available for 688289.SS's 2026-04-30 report.
What is 688289.SS's current P/E ratio and EPS?
688289.SS trades at a trailing P/E of 57.31 on trailing EPS of 0.2524220042318707 CNY.
What do analysts rate 688289.SS?
688289.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.